Alpelisib is a selective kinase inhibitor belonging to the PI3K-alpha inhibitor class, used in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer in patients harboring specific… Read more




Alpelisib is a selective kinase inhibitor belonging to the PI3K-alpha inhibitor class, used in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer in patients harboring specific PIK3CA mutations. This medication functions by inhibiting the PI3K/AKT/mTOR signaling pathway to suppress tumor cell growth and is typically administered in combination with endocrine therapy. This category provides a comprehensive selection of Alpelisib reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, method validation, and impurity profiling throughout drug development and manufacturing. By utilizing high-quality reference standards and stable isotope-labelled internal standards, researchers can ensure accurate quantification and regulatory compliance during quality control procedures, facilitating the assessment of API purity and the identification of potential degradation products or synthesis-related impurities.